alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › aspects

aspects

4 studies tagged aspects, dated 1993-01-01 to 2011-11-02. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative 2011-11-02
  2. Neurobiological aspects of Alzheimer's disease 2011-02-11
  3. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects 2009-09-29

Studies

4 studies carry this tag.

Date range

1993 to 2011

Top journals

  • Advances in neurology 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Experimental gerontology 1
  • Expert opinion on therapeutic targets 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2011-11-02 Tau biomarkers

    The consensus reached on preanalytical issues and the recommendations put forward during the ABSI consensus meetings are presented in this paper.

  2. Neurobiological aspects of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Expert opinion on therapeutic targets 2011-02-11 Treatments

    From a biochemical point of view the most consistent finding is a decreased level of choline acetyltransferase.

  3. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Experimental gerontology 2009-09-29 Genetics

    An early diagnosis of Alzheimer's disease (AD) and other types of dementia-causing disorders is vital in order to achieve effective treatments.

  4. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Advances in neurology 1993-01-01 Drug development

    This chapter reports the clinical and neuropathological findings of eight cases of "diffuse Lewy body disease" verified by autopsy.

All topic tags with their study counts